Newsbenzinga
Theravance Biopharma Discloses Termination Fee Of $32.5M After Acquisition Offer By Zymeworks
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…